30. Berberine | Promise, Pitfalls & Perspective

In this episode of Mohivate, Dr Mohi Sarawgee explores berberine, one of the most talked about metabolic supplements right now, bringing clarity to a conversation often shaped more by social media than by science.
Berberine is a naturally occurring alkaloid with thousands of years of history in Ayurvedic and traditional Chinese medicine. This episode traces how it moved from gut medicine to metabolic science, unpacking the mechanisms behind its effects on blood sugar, insulin resistance, lipid metabolism, and the PCSK9 pathway, the same cholesterol target that billion dollar injectable medications were developed to address.
The episode examines the clinical evidence honestly, including the landmark head to head comparison with metformin, the 2025 meta-analysis data, and the real limitations of the current evidence base. It covers who berberine is actually used in, what the safety and interaction profile looks like, and why formulation and dose matter more than most supplement labels suggest.
With clinical insight and a GP’s perspective, this episode gives berberine the conversation it deserves.

REFERENCES
1. Berberine and Metabolic Syndrome — 2025 Systematic Review and Meta-Analysis
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1572197/full
2. Berberine Health Outcomes — Overview of 54 Systematic Reviews
https://link.springer.com/article/10.1186/s12906-025-04872-4
3. Berberine vs Metformin — Head to Head Trial. Zhang Y et al. 
https://academic.oup.com/jcem/article/93/7/2559/2598177
4. Berberine as a Novel Cholesterol Lowering Drug — PCSK9 and LDL Receptor Mechanism
Kong W et al.
Nature Medicine, 2004
https://www.nature.com/articles/nm1135
5. Berberine PCSK9 Inhibition — Review
Berberine: Ins and outs of a nature-made PCSK9 inhibitor
https://www.excli.de/excli/article/view/5234
6. Berberine Bioavailability and Gut Microbiome
https://www.mdpi.com/1424-8247/18/2/193
7. Berberine and NAFLD — 2024 Meta-Analysis
https://pubmed.ncbi.nlm.nih.gov
8. Dihydroberberine vs Standard Berberine HCl — 2021 RCT
https://pubmed.ncbi.nlm.nih.gov/35010998/
9. Berberine and PCOS — 2024 Meta-Analysis
https://pubmed.ncbi.nlm.nih.gov
10. Semaglutide Cardiovascular Outcomes — NEJM
https://www.nejm.org/doi/full/10.1056/NEJMoa1607141
11. Semaglutide Weight Loss — STEP Trial
Wilding JPH et al.
New England Journal of Medicine, 2021
https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
12. AMPK as Metabolic Master Switch — Review
Hardie DG. 
https://onlinelibrary.wiley.com/doi/10.1111/joim.12268
13. Berberine Drug Interactions — CYP450
Guo Y et al.
https://pubmed.ncbi.nlm.nih.gov/21987089/
14. Berberine Contraindication in Pregnancy
Liu W et al.
Available via PubMed safety data:
https://pubmed.ncbi.nlm.nih.gov

Just a gentle reminder: this episode is for information, education, and inspiration only. It’s not a substitute for your doctor’s advice. For any personal health concerns, always seek guidance from your doctor.

Transcript

SPEAKER_00 0:04

Hi everyone, welcome back to Mohivate. I'm Dr. Mohi Saraugi, a GP by profession, but here I'm swapping prescriptions for perspective. Over the last few weeks, we've been exploring metabolic health together, and I hope you found it useful. Today we are staying in the same metabolic world, just walking into a different room, the supplement room. The global supplement industry is now worth over$200 billion. Walk into any pharmacy, scroll through any wellness account, or sit in any doctor's waiting room, and you'll find someone taking something. Sometimes many somethings. The average person these days takes somewhere between 6 and 10 supplements every day. And then there is a certain gentleman, you may have seen his Netflix documentary, who has decided that aging is negotiable. Over a hundred supplements a day, a team of doctors monitoring his every biomarker, and a monthly spend that would cover an entire street's worth of rent or mortgage. Now I am not against supplements, I take them myself. Many of them have genuine science behind them. But beyond the marketing, before you take anything available over the counter, the question worth asking is simply this What does the science actually say? Because we are living through a metabolic health crisis: diabetes, insulin resistance, PCOS, obesity, fatty liver disease, and metabolic syndrome. These conditions are becoming increasingly common and people are suffering. The waiting lists to see a doctor are long, medications have side effects, and supplements are comparatively cheap, accessible, and critically all over social media. So people are going to take them. The question was never really whether they would or should. The real question is what the evidence actually says. Today on Mohivate, we begin our conversation on metabolic supplements: berberine, myoinositol, cinnamon, alpha lipoic acid, and others. Some with solid signs, some honorable mentions. We will get to all of them on Mohivate. But today, let's start with the one everyone is talking about. What does it genuinely do? Who benefits from it? Where does the evidence hold up? And where does it fall short? And why, before any of this, should the conversation always start with your doctor? So let's begin. If metabolic supplements had a pop star, it would be berberine. Arriving at the red carpet in a limousine, documentary deal in hand, 3 million TikTok views and counting. It has been called and let's brace ourselves. We will come back to that with evidence. So, what is berberine? It is a naturally occurring alkaloid, a bioactive compound extracted from a family of plants. Berberis vulgaris, also known as barbery, as well as gold thread and golden seal. Bright yellow in color, so vivid that it was historically used as a textile dye. Now, berberine as we know it today comes in a standardized, concentrated, extracted form. And as we will discuss how berberine is formulated matters quite a lot. Berberine's medicinal history goes back thousands of years. Initially used in Ayurvedic and traditional Chinese medicine for gut infections, diarrhoea and gastrointestinal inflammation. The glucose connection came almost accidentally. Patients taking berberine for gut conditions kept showing up with improved blood sugar levels. Researchers noticed, and in the early 2000s, that is where the metabolic science behind berberine began. So, how does berberine work? Berberine activates something called AMPK, adenosine monophosphate-activated protein kinase. Think of AMPK as your body's master fuel gauge. When energy is low, AMPK fires up and tells your cells one thing. Stop storing, start burning. When AMPK activates, it drives glucose transporters to the surface of your cells. Think of these transporters as little doors on the cell wall. When they open, glucose walks in, blood sugar comes down. Now, if you've been following our previous episodes, you know that insulin is normally the key that opens those doors. But in insulin resistance, the insulin signal is broken. The key no longer fits. Berberine bypasses that broken lock and opens a different door entirely. Glucose gets into the cell anyway, independently of insulin. And that AMPK pathway, that is the same pathway activated by metformin, the most prescribed diabetes medication in the world. The overlaps are real, and that is exactly why the science behind it is taken seriously. Berberine also slows carbohydrate absorption in the gut, similar to another diabetes medication called acarbose. One molecule, multiple pathways. The mechanism on paper is genuinely impressive. But before we get to the clinical data, there's one more thing berberine does. And this one is something evolving even for us as clinicians. Something we are genuinely watching. Berberine is a natural PCSK9 inhibitor. Let me explain what that means because it matters. Your liver has receptors on its surface. Think of them as little nets. Their job is to catch LDL cholesterol, what we commonly call bad cholesterol, from your bloodstream and pull it into the liver to be cleared. The more nets you have working, the more LDL gets cleared, the less bad cholesterol stays in your blood. Now your body also produces a protein called PCSK9, and PCSK9 is the demolition crew. Its entire job is to destroy those nets. The more PCSK9 you have, the more nets get destroyed, the less LDL gets cleared, and the more bad cholesterol builds up in your bloodstream. And what causes PCSK9 to rise? The very same conditions we are discussing today. Poor diet, obesity, insulin resistance. The demolition crew gets bigger exactly when you can least afford to lose those nets. So the goal, medically speaking, is to reduce that demolition crew. Less PCSK9 means more nets intact and more LDL cleared. Better for your heart, better for your arteries. And that is exactly what the pharmaceutical industry spent billions trying to achieve. They developed injectable medications, specific monoclonal antibodies to block PCSK9. Given every two to four weeks, they are extraordinarily effective at lowering LDL. Also, extraordinarily expensive, thousands of pounds or dollars per year. For many patients, particularly those with genetic cholesterol conditions, they have been genuinely life-changing. These are specialist medications with specific prescribing criteria, not something to self-refer for. And here is where berberine becomes interesting. Berberine has been shown to naturally reduce PCSK9. Not in the same way as those injectable drugs, but it turns down the signal that tells your body to make PCSK9 in the first place. Less demolition crude being produced, more nets surviving, more LDL being cleared from your bloodstream. Now, the most commonly prescribed cholesterol-oring medications in the world are statins. And statins work through a completely different pathway by blocking an enzyme called HMG CoA reductase, which reduces cholesterol production in the liver. Berberine does not replace statins, but because it works through a different mechanism entirely, the two can complement each other rather than simply overlap. And for the patient who cannot tolerate statins, this is a mechanism worth knowing about. The evidence is still emerging, but as a GP, I find it genuinely interesting when a plant-derived compound shows up in the same conversation as billion-dollar pharmaceutical targets. That does not happen often and it is worth paying attention to. So now we have the mechanism, we have the pathways. But who is berberine actually being used in? Primarily people with prediabetes, type 2 diabetes, and metabolic syndrome who want an adjunct to lifestyle changes, people with PCOS where insulin resistance is a driving factor, and those with non-alcoholic fatty liver disease. We also discuss the emerging interest in berberine for cholesterol management. But that is a conversation to have with your doctor, not something to self-initiate, and certainly not a reason to stop a statin that is working for you. Please remember berberine is not a first-line treatment. It is not a replacement for medication in those who need it. But as a supplement, as an adjunct, the data is worth knowing. So, what does the research actually show? A 2025 systematic review and meta-analysis using some of the most rigorous research methodology we have in medicine found that berberine significantly reduced LDL, total cholesterol, triglycerides, fasting plasma glucose, BMI, and waste circumference in people with metabolic syndrome. Simply put, it moved the numbers that matter. And then there was a separate 2025 overview which pulled together 54 systematic reviews and looked at berberine across 70 different health measurements in 9 different diseases. Think of it as a review of reviews, the big picture. And what it found was that in people with type 2 diabetes, berberine improved over 92% of the markers being tracked. In metabolic syndrome, over 90%, not one marker, over 90% of everything they measured moved in the right direction. That is not a small finding. But the study I want to highlight because it is the one that made the medical community sit up and pay attention, compared berberine directly with metformin in newly diagnosed type 2 diabetic patients. Two groups, one took metformin, the other took berberine, both for three months. The results? Berberine reduced HPA1C, fasting glucose, and postmeal glucose comparably to metformin. Comparable, not identical, not superior, comparable. And here is a clinical nuance worth mentioning. If you have ever taken metformin or know someone who has, you will know it can come with gastrointestinal side effects. Nausea, a gassy tummy, loose tools. Berberine can do the same. However, the trial showed that berberine produced fewer GI side effects in some patients. For a plant-derived compound to sit in the same conversation as the most prescribed diabetes medication in the world, that is significant. And on cholesterol, clinical trials have shown reduction in total cholesterol of up to 29% and LDL by 25%, connecting directly back to everything we discussed about PCSK9. But here is where I have to be the annoying doctor who loves data for a moment. The evidence base, while genuinely growing, has real limitations. And I think it is important to say this clearly. The heterogeneity across trials is significant. Most studies are short term, under six months. Many of the strongest studies come from Chinese research institutions, and while that does not invalidate them, methodological riger and publication bias are legitimate considerations. I say that with respect. Some of the most important pharmacological research in the world comes from China. But as clinicians and researchers, we ask these questions of every evidence base. Berberine is no exception. The 2025 meta-analysis itself stated explicitly that the current evidence is insufficient to claim syndrome-level remission, meaning we cannot yet say berberine reverses metabolic syndrome completely. Metformen has 70 years of evidence behind it. Berberine does not. But here's what I will say: the signal is real, the effect sizes are real, the evidence base is still maturing. This is not a dismissal, it is an honest assessment of where we are. And it is exactly why I describe berberine as something to watch, not something to depend on blindly. And one final practical point before we move on. Unlike metformin, where kidney function is monitored regularly, berberine has no mandated monitoring protocol as it is a supplement and not a licensed medication. If you're taking it or thinking about starting, the conversation with your doctor matters. Personalized guidance always beats a supplement label. So I have thrown a lot of science at you and I hope you're still with me because there's one more thing that happens to be one of my favorite berberine facts. Berberine has an oral bioavailability of less than 1%. Less than 1%. In pharmaceutical terms, that is terrible. If a drug company brought berberine to a development meeting and said a compound has less than 1% bioavailability, they would be shown the door. What this means in practice is that berberine struggles to get through the gut wall. It gets ambushed in the acidic gut environment. And whatever does manage to sneak through faces one final obstacle, the liver. This is what we call first metabolism. Before anything you swallow reaches your bloodstream, it has to pass through the liver first. And the liver, brilliant organ that it is, looks at berberine and says, not on my watch. It breaks a significant portion of it down before it ever gets a chance to circulate. By the time berberine finally arrives in your bloodstream, the party is nearly over. And yet it works. The clinical data we just discussed is real. So how? The leading theory is that berberine may be doing much of its metabolic work not by getting into your bloodstream, but by staying in your gut. That 99% that never gets absorbed spends significant time in your intestinal humen. And while it is there, it reshapes your gut microbiome, promotes beneficial bacteria, reduces pro-inflammatory species. It increases the production of short-chain fatty acids. Think of these as the good stuff your gut bacteria produce when they are well fed. They repair your gut lining, reduce inflammation, and send signals back into your metabolism that improve insulin sensitivity. In other words, berberine may be a gut drug pretending to be a systemic one, which is why two people can take the same dose and have completely different experiences. And this is exactly why, as I mentioned earlier, formulation matters. The standard form you will find in most supplements is berberine hydrochloride, berberine HCl, most studied in clinical trials, most affordable. There are also newer formulations on the market: berberine phytozome and dihydroberberine, a reduced form that reaches the bloodstream more efficiently. Both are commercially available, both are more expensive. And interestingly, more bioavailable does not automatically mean more effective. So if you're standing in a pharmacy or scrolling through a supplement website, here is the practical guidance. Look for berberine HCl, sauce from Berberis aristata or berberis vulgaris 500 milligrams. This is the right starting point for most people. And whatever you buy, third-party tested. Because with supplements, unlike medications, nobody is mandated to check what is actually in the bottle. Now, before we close the berberine discussion, there is a section I will not skip, and I say this as your GP on this podcast. Please do not skip it either. Interactions and safety. Berberine inhibits certain liver enzymes called CYP3A4 and CYP2D6, responsible for metabolizing many commonly prescribed medications. Simply put, berberine can make certain drugs stronger or interfere with how they are broken down. The interactions worth knowing about specifically, if you're on metformin or insulin, berberine adds to the glucose lowering effect. That combination can cause hypoglycemia, low blood sugar, and low blood sugar, it's not something to be casual about. If you're on a statin, berberine works through a complementary mechanism as we discussed. But combining them needs a supervised conversation, not a self-initiated one. If you are on warfarin or an anticoagulant, berberine can amplify the blood thinning effect. This needs monitoring. If you're on cyclosporin, an immunosuppressant used after organ transplants or in autoimmune conditions, berberine can significantly increase cyclosporine levels in the blood. This one is serious. Doctor's input essential. And the absolute non-negotiable one, berberine, is contraindicated in pregnancy. Animal studies have shown it can stimulate uterine contractions and fetal toxicity has been documented. If you are pregnant, trying to conceive or breastfeeding, berberine is not for you. Full stop. On side effects, nausea, bloating, loose tools, constipation, dose-dependent. Usually settle within two to three weeks. Start low at 500 mg per day and build up gradually. What we call titrating. Always take it with food. The dose used in most clinical trials is 500 mg, 2 to 3 times daily with meals. Berberine has a short half-life of around 4 to 5 hours, which is exactly why splitting the dose across the day matters. Total daily dose of 1000 to 1500 milligrams. Please do not exceed this without medical guidance. And I say please with full intention because I have seen discussions on social media recommending 2000 milligrams of berberine. I'm not here to shame anyone. Everyone is on their own health journey. And I say this with love. Sometimes more is simply more side effects and a lighter wallet. Context matters, your medical history matters, your medications matter, and your physiology matters. Your safety is not something a social media post can personalize for you. And finally, let's address the claim that started this whole conversation. Nature's Ozempic. Let's deal with this properly because berberine deserves better than a label it cannot live up to. Sold as Ozempic for diabetes and Vigovi for weight loss drives 10 to 15% body weight loss in clinical trials. It has been shown to reduce major adverse cardiovascular events, shown benefits in heart failure, chronic kidney disease, and non-alcoholic fatty liver disease. It works by mimicking a hormone called GLP1, glucagon-like peptide 1, which your gut naturally releases after eating. It tells your brain you're full, it slows stomach emptying, it reduces appetite, it operates at a hormonal level that berberine simply does not touch. Berberine is not that. Yes, berberine may support modest weight loss in some people, likely through improvements in insulin sensitivity, glucose handling, and metabolic efficiency. Clinical trials show approximately 2 to 3 kilograms over 12 weeks in most studies. That is not 10 to 15% of body weight, and that is simply the honest weight loss profile of berberine based on current evidence. A more accurate description would be this berberine is closer to nature's mild metformin with a surprisingly interesting cholesterol chapter. As you heard today, it overlaps AMPK pathways, produces real glucose and lipid benefits, and inhibits a PCSK9 mechanism that the pharmaceutical industry spent billions trying to replicate. Available without a prescription at a fraction of the cost. That is genuinely useful. That still matters for a lot of patients. It is just not ozempic. Calling it that sets expectations the evidence cannot meet, and ultimately it undermines trust in a supplement that actually has something real to offer. So please don't believe the oversell. Give berberine the credit it has earned, not the credit it has not. Scientific hype, dressed up in a wellness aesthetic, is still hype and your body deserves better than that. So that is berberine. One supplement, thousands of years of history, and a science story still being written. I hope something from today stayed with you. Whether it was a mechanism that made you think, a safety point that made you pause, or simply the reminder that your biology deserves more than a midnight impulse purchase. If this episode gave you something useful or thoughtful, please do share it with someone who might benefit from it. From the 19th of April 2026, Mohivate will also be available on YouTube as an audio podcast. And if you're enjoying these episodes, please consider following, rating, commenting, or leaving a review on whichever platform you listen on. It genuinely helps the podcast grow, helps it reach more people, and truly keeps me going. Thank you for listening. I'm Dr. Mohi. Until next time, remember this health is rarely built in impulse or in hype. It is built in thoughtful choices, in patience, in consistency, and in the kind of self respect that slowly brings you back to coming home to yourself.